Summary

Report Scope
The report provides an overview of the global cardiovascular devices market and analyzes market trends. It includes global revenue ($ million) using 2024 as the base year, estimated data for 2025, and projected data for 2026 through 2030.
The market is segmented by product and end user. Based on product, the cardiovascular devices market is segmented into interventional cardiology, cardiac rhythm management, diagnostics and monitoring, cardiac assist devices, electrophysiology, and other vascular surgery devices. Based on end users, the market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic laboratories, and other end users. Geographical regions covered in this study are North America (the U.S., Canada, and Mexico), Europe (Germany, the U.K., Italy, France, Spain, and the rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia-Pacific), the Middle East and Africa (MEA), and South America, focusing on all the major countries in these regions.
The report focuses on the key driving trends and challenges shaping the market and vendor landscape. It analyzes and discusses emerging technologies related to the market.
The report concludes by analyzing the competitive landscape and providing the leading global cardiovascular devices companies. It also includes a dedicated section of company profiles that covers overviews, key financials, product portfolios, and recent developments for major companies.
Report Includes
- 69 data tables and 73 additional tables
- An overview and analysis of the global cardiovascular devices market
- Analyses of global market trends, with revenue data for 2022-2025, and projections of CAGRs through 2030
- Estimates of the current market size and future revenue growth prospects, accompanied by a market share analysis by product, end user, and region
- Facts and figures pertaining to market dynamics, including key drivers, restraints, opportunities, challenges, and the impact of macroeconomic factors
- Review of regulatory frameworks across major regions, along with an assessment of approval pathways and compliance requirements
- Insights into emerging technologies and developments, including innovations in minimally invasive devices, remote patient monitoring, and implantable cardiovascular technologies
- Patent analysis highlighting key granted and published patents related to cardiovascular medical devices
- Analysis of the competitive landscape, including company market share rankings, strategic initiatives, partnerships, and recent developments
- Overview of sustainability trends and ESG developments in the global cardiovascular devices market
- Profiles of the leading global companies, including Medtronic, Abbott, Boston Scientific Corp., Edwards Lifesciences Corp., and Johnson & Johnson

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Technological Advances
Conclusion
Chapter 2 Market Overview
Overview
Type of Cardiovascular Diseases
Coronary Artery Disease
Arrhythmia
Structural Heart Disease
Heart Infection
Cardiovascular Procedures Volume
Cardiovascular Procedures Cost
Porter’s Five Forces Analysis in the Technologies for Cardiovascular Devices Market
Potential for New Entrants (Low to Moderate)
Bargaining Power of Suppliers (Moderate)
Bargaining Power of Buyers (Moderate)
Threat of Substitutes (Low)
Competition in the Industry (High)
Macroeconomic Factor Analysis
Urbanization and Lifestyle Changes
Shortage of Skilled Professionals
U.S. Tariff Scenario
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Rising Prevalence of Cardiovascular Disorders and Other Lifestyle-Related Disorders
Growing Demand for Minimally Invasive Procedures in Cardiovascular Treatment
Increasing Adoption of Remote Patient Monitoring for Cardiac Disease Management
Market Restraints
Stringent Product Approval Guidelines
High Cost of Advanced Cardiovascular Devices and Procedures
Market Opportunities
Growing Demand for Preventive and Early-Diagnosis Solutions
Increasing Focus on Value-Based Healthcare
Market Challenges
Complex Product Development
Complications Associated with Implantable Devices
Chapter 4 Regulatory Landscape
U.S.
Europe
Other Regions
Chapter 5 Emerging Technologies and Developments
Emerging Technologies
Leadless and Wireless Cardiac Implants
Bioresorbable Cardiac Devices
Wearable Cardiac Devices
Total Artificial Heart
Artificial Intelligence
Patent Analysis
Key Takeaways
Patents, by Year
By Top Applicant
By Top Owner
By Jurisdiction
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis by Product
Key Takeaways
Interventional Cardiology
Cardiac Rhythm Management
Diagnostics and Monitoring
Cardiac Assist Devices
Electrophysiology
Other Vascular Surgery Devices
Market Analysis by End User
Key Takeaways
Hospitals and Clinics
Ambulatory Surgical Centers
Diagnostics Laboratories
Other End Users
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa (MEA)
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Landscape
Leading Companies in the Global Cardiovascular Devices Market
Medtronic
Abbott
Boston Scientific Corp
Edward
Johnson & Johnson
Key Developments and Strategies
Chapter 8 Appendix
Methodology
Sources
Abbreviations
Company Profiles
ABBOTT
BAXTER
B. BRAUN SE
BIOTRONIK
BOSTON SCIENTIFIC CORP.
BPL MEDICAL TECHNOLOGIES
COOK
EDWARDS LIFESCIENCES CORP.
GE HEALTHCARE
JOHNSON & JOHNSON
KONINKLIJKE PHILIPS N.V.
MEDTRONIC
NIHON KOHDEN CORP.
SIEMENS HEALTHINEERS AG
TERUMO CORP.
Few Emerging Start-Ups/ Market Disruptors

ページTOPに戻る

List of Tables/Graphs

List of Tables
Summary Table : Global Market for Cardiovascular Devices, by Region, Through 2030
Table 1 : Cardiovascular Diseases: Modifiable Risk Factors
Table 2 : Global: Annual Cardiac Surgical Volumes per 100,000 Population Per Year
Table 3 : Cost of Cardiovascular Surgery, by Country, 2025
Table 4 : Porter’s Five Forces Analysis: Overview
Table 5 : Global Cardiovascular Disease: Prevalence and Deaths, 2023
Table 6 : Advantages of Remote Patient Monitoring
Table 7 : Cardiovascular Care Programs Driving Value-Based Outcomes and Cost Efficiency
Table 8 : Complications Associated with Implantable Devices
Table 9 : FDA Regulatory Pathways and Cardiovascular Device Classification Overview
Table 10 : EU Medical Device Regulatory Pathway
Table 11 : Other Region: Cardiovascular Regulatory Landscape
Table 12 : List of Wearable Cardiac Devices
Table 13 : Total Artificial Heart, Company Comparison, 2026
Table 14 : AI in Cardiology: Application
Table 15 : Patents, by Top Applicant, 2022–2025
Table 16 : Patents, by Top Owner, 2022–2025
Table 17 : Patents, by Jurisdiction, 2022–2025
Table 18 : Global Market for Cardiovascular Devices Market, by Product, Through 2030
Table 19 : TAVR Systems, by Company
Table 20 : TMVR Systems, by Company
Table 21 : Major Catheters in Interventional Cardiology
Table 22 : Type of Cardiovascular Stent
Table 23 : Advances in Drug-Eluting Stents
Table 24 : Global Market for Interventional Cardiology, by Type, Through 2030
Table 25 : Pacemaker, by Company
Table 26 : Advances in Pacemakers
Table 27 : CRT Devices, by Company
Table 28 : ICD Devices, by Company
Table 29 : Global Market for Cardiac Rhythm Management, by Type, Through 2030
Table 30 : Different Types of ECG
Table 31 : ECG Products, by Type
Table 32 : Different Types of Echocardiographs
Table 33 : Echocardiograph, by Company
Table 34 : Global Market for Diagnostics and Monitoring, by Type, Through 2030
Table 35 : Ventricular Assist Device, by Company
Table 36 : Intra-Aortic Balloon Pump, by Company
Table 37 : Global Market for Cardiac Assist Devices, by Type, Through 2030
Table 38 : Global Market for Electrophysiology, by Type, Through 2030
Table 39 : Global Market for Other Vascular Surgery Devices, by Type, Through 2030
Table 40 : Global Market for Cardiovascular Devices, by End User, Through 2030
Table 41 : Global Market for Cardiovascular Devices, by Region, Through 2030
Table 42 : North American Market for Cardiovascular Devices, by Country, Through 2030
Table 43 : North American Market for Cardiovascular Devices, by Product, Through 2030
Table 44 : North American Market for Interventional Cardiology, by Type, Through 2030
Table 45 : North American Market for Cardiac Rhythm Management, by Type, Through 2030
Table 46 : North American Market for Diagnostics and Monitoring, by Type, Through 2030
Table 47 : North American Market for Cardiac Assist Devices, by Type, Through 2030
Table 48 : North American Market for Electrophysiology, by Type, Through 2030
Table 49 : North American Market for Other Vascular Surgery Devices, by Type, Through 2030
Table 50 : North American Market for Cardiovascular Devices, by End User, Through 2030
Table 51 : European Market for Cardiovascular Devices, by Country, Through 2030
Table 52 : European Market for Cardiovascular Devices, by Product, Through 2030
Table 53 : European Market for Interventional Cardiology, by Type, Through 2030
Table 54 : European Market for Cardiac Rhythm Management, by Type, Through 2030
Table 55 : European Market for Diagnostics and Monitoring, by Type, Through 2030
Table 56 : European Market for Cardiac Assist Devices, by Type, Through 2030
Table 57 : European Market for Electrophysiology, by Type, Through 2030
Table 58 : European Market for Other Vascular Surgery Devices, by Type, Through 2030
Table 59 : European Market for Cardiovascular Devices, by End User, Through 2030
Table 60 : Asia-Pacific Market for Cardiovascular Devices, by Country, Through 2030
Table 61 : Asia-Pacific Market for Cardiovascular Devices, by Product, Through 2030
Table 62 : Asia-Pacific Market for Interventional Cardiology, by Type, Through 2030
Table 63 : Asia-Pacific Market for Cardiac Rhythm Management, by Type, Through 2030
Table 64 : Asia-Pacific Market for Diagnostics and Monitoring, by Type, Through 2030
Table 65 : Asia-Pacific Market for Cardiac Assist Devices, by Type, Through 2030
Table 66 : Asia-Pacific Market for Electrophysiology, by Type, Through 2030
Table 67 : Asia-Pacific Market for Other Vascular Surgery Devices, by Type, Through 2030
Table 68 : Asia-Pacific Market for Cardiovascular Devices, by End User, Through 2030
Table 69 : South American Market for Cardiovascular Devices, by Product, Through 2030
Table 70 : South American Market for Interventional Cardiology, by Type, Through 2030
Table 71 : South American Market for Cardiac Rhythm Management, by Type, Through 2030
Table 72 : South American Market for Diagnostics and Monitoring, by Type, Through 2030
Table 73 : South American Market for Cardiac Assist Devices, by Type, Through 2030
Table 74 : South American Market for Electrophysiology, by Type, Through 2030
Table 75 : South American Market for Other Vascular Surgery Devices, by Type, Through 2030
Table 76 : South American Market for Cardiovascular Devices, by End User, Through 2030
Table 77 : MEA Market for Cardiovascular Devices, by Product, Through 2030
Table 78 : MEA Market for Interventional Cardiology, by Type, Through 2030
Table 79 : MEA Market for Cardiac Rhythm Management, by Type, Through 2030
Table 80 : MEA Market for Diagnostics and Monitoring, by Type, Through 2030
Table 81 : MEA Market for Cardiac Assist Devices, by Type, Through 2030
Table 82 : MEA Market for Electrophysiology, by Type, Through 2030
Table 83 : MEA Market for Other Vascular Surgery Devices, by Type, Through 2030
Table 84 : MEA Market for Cardiovascular Devices, by End User, Through 2030
Table 85 : Global Market Share Analysis for Cardiovascular Devices, by Company, 2024
Table 86 : Cardiovascular Devices: Recent Strategic Developments, 2024–2026
Table 87 : Report Information Sources
Table 88 : Abbreviations Used in the Cardiovascular Devices Market Report
Table 89 : Abbott: Company Snapshot
Table 90 : Abbott: Financial Performance, FY 2023 and 2024
Table 91 : Abbott: Product Portfolio
Table 92 : Abbott: News/Key Developments, 2023–2025
Table 93 : Baxter: Company Snapshot
Table 94 : Baxter: Financial Performance, FY 2023 and 2024
Table 95 : Baxter: Product Portfolio
Table 96 : B. Braun SE: Company Snapshot
Table 97 : B. Braun SE: Financial Performance, FY 2023 and 2024
Table 98 : B. Braun SE: Product Portfolio
Table 99 : Biotronik: Company Snapshot
Table 100 : Biotronik: Product Portfolio
Table 101 : Biotronik: News/Key Developments, 2023–2025
Table 102 : Boston Scientific Corp.: Company Snapshot
Table 103 : Boston Scientific Corp.: Financial Performance, FY 2023 and 2024
Table 104 : Boston Scientific Corp.: Product Portfolio
Table 105 : Boston Scientific Corp.: News/Key Developments, 2024–2026
Table 106 : BPL Medical Technologies: Company Snapshot
Table 107 : BPL Medical Technologies: Product Portfolio
Table 108 : Cook: Company Snapshot
Table 109 : Cook: Product Portfolio
Table 110 : Edwards Lifesciences Corp.: Company Snapshot
Table 111 : Edwards Lifesciences Corp.: Financial Performance, FY 2023 and 2024
Table 112 : Edwards Lifesciences Corp.: Product Portfolio
Table 113 : Edwards Lifesciences Corp.: News/Key Developments, 2024–2025
Table 114 : GE HealthCare: Company Snapshot
Table 115 : GE HealthCare: Financial Performance, FY 2023 and 2024
Table 116 : GE HealthCare: Product Portfolio
Table 117 : GE HealthCare: News/Key Developments, 2023
Table 118 : Johnson & Johnson: Company Snapshot
Table 119 : Johnson & Johnson: Financial Performance, FY 2023 and 2024
Table 120 : Johnson & Johnson: Product Portfolio
Table 121 : Johnson & Johnson: News/Key Developments, 2023-2025
Table 122 : Koninklijke Philips N.V.: Company Snapshot
Table 123 : Koninklijke Philips N.V.: Financial Performance, FY 2023 and 2024
Table 124 : Koninklijke Philips N.V.: Product Portfolio
Table 125 : Medtronic: Company Snapshot
Table 126 : Medtronic: Financial Performance, FY 2023 and 2024
Table 127 : Medtronic: Product Portfolio
Table 128 : Medtronic: News/Key Developments, 2023-2025
Table 129 : Nihon Kohden Corp.: Company Snapshot
Table 130 : Nihon Kohden Corp.: Financial Performance, FY 2023 and 2024
Table 131 : Nihon Kohden Corp.: Product Portfolio
Table 132 : Nihon Kohden Corp.: News/Key Developments, 2024
Table 133 : Siemens Healthineers AG: Company Snapshot
Table 134 : Siemens Healthineers AG: Financial Performance, FY 2023 and 2024
Table 135 : Siemens Healthineers AG: Product Portfolio
Table 136 : Siemens Healthineers AG: News/Key Developments, 2023
Table 137 : Terumo Corp.: Company Snapshot
Table 138 : Terumo Corp.: Financial Performance, FY 2023 and 2024
Table 139 : Terumo Corp.: Product Portfolio
Table 140 : Terumo Corp.: News/Key Developments, 2025
Table 141 : List of a Few Emerging Start-Ups/ Market DisruptorsList of Figures
Summary Figure : Global Market Shares of Cardiovascular Devices, by Region, 2024
Figure 1 : Heart Bypass Surgery Cost Structure, India, 2025
Figure 2 : Porter’s Five Forces Analysis of the Technologies for Cardiovascular Devices Market
Figure 3 : Snapshot of Market Dynamics of Cardiovascular Devices
Figure 4 : Advantages of Minimally Invasive Procedures in Cardiovascular Treatment
Figure 5 : CARDIOLOGY: Remote Patient Monitoring Solutions
Figure 6 : Challenges in Cardiovascular Device Manufacturing
Figure 7 : Emerging Trends/Technologies in the Cardiovascular Devices Market
Figure 8 : Patents Granted, by Year, 2022–2025
Figure 9 : Global Market Shares of Cardiovascular Devices, by Product, 2024
Figure 10 : Global Market Shares of Cardiovascular Devices, by End User, 2024
Figure 11 : Global Market Shares of Cardiovascular Devices, by Region, 2024
Figure 12 : North American Market Shares of Cardiovascular Devices, by Country, 2024
Figure 13 : European Market Shares of Cardiovascular Devices, by Country, 2024
Figure 14 : Asia-Pacific Market Shares of Cardiovascular Devices, by Country, 2024
Figure 15 : Abbott: Revenue Shares, by Business Unit, FY 2024
Figure 16 : Abbott: Revenue Shares, by Country/Region, FY 2024
Figure 17 : Baxter: Revenue Shares, by Business Unit, FY 2024
Figure 18 : Baxter: Revenue Shares, by Country/Region, FY 2024
Figure 19 : B. Braun SE: Revenue Shares, by Business Unit, FY 2024
Figure 20 : B. Braun SE: Revenue Shares, by Country/Region, FY 2024
Figure 21 : Boston Scientific Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 22 : Boston Scientific Corp.: Revenue Shares, by Country/Region, FY 2024
Figure 23 : Edwards Lifesciences Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 24 : Edwards Lifesciences Corp.: Revenue Shares, by Country/Region, FY 2024
Figure 25 : GE HealthCare: Revenue Shares, by Business Unit, FY 2024
Figure 26 : GE HealthCare: Revenue Shares, by Country/Region, FY 2024
Figure 27 : Johnson & Johnson: Revenue Shares, by Business Segment, FY 2024
Figure 28 : Johnson & Johnson: Revenue Shares, by Country/Region, FY 2024
Figure 29 : Koninklijke Philips N.V.: Revenue Shares, by Business Unit, FY 2024
Figure 30 : Koninklijke Philips N.V.: Revenue Shares, by Country/Region, FY 2024
Figure 31 : Medtronic: Revenue Shares, by Business Unit, FY 2024
Figure 32 : Medtronic: Revenue Shares, by Region/Country, FY 2024
Figure 33 : Nihon Kohden Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 34 : Nihon Kohden Corp.: Revenue Shares, by Region/Country, FY 2024
Figure 35 : Siemens Healthineers AG: Revenue Shares, by Business Unit, FY 2024
Figure 36 : Siemens Healthineers AG: Revenue Shares, by Country/Region, FY 2024
Figure 37 : Terumo Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 38 : Terumo Corp.: Revenue Shares, by Country/Region, FY 2024